Brief: Interpace Diagnostics Enters Agreement With Predictive Oncology To Enhance Diagnosis Of Thyroid Cancer Via AI-Driven Analysis

Interpace Biosciences

18/07/2019 12:16

July 18 (Reuters) - Interpace Diagnostics Group Inc
 IDXG.O :
    * INTERPACE DIAGNOSTICS ENTERS AGREEMENT WITH PREDICTIVE
ONCOLOGY
TO ENHANCE DIAGNOSIS OF THYROID CANCER VIA AI-DRIVEN ANALYSIS
    * INTERPACE DIAGNOSTICS - COS EXPECT TO DEVELOP PRODUCTS
THAT
DIAGNOSE AND ASSESS RISK FOR THYROID CANCER AS WELL AS PROVIDE
THERAPEUTIC RECOMMENDATIONS

Source text for Eikon:  ID:nGNX6tgZDz 
Further company coverage:  IDXG.O 

 (((Reuters.Briefs@thomsonreuters.com);))